B-cell Lymphoma Clinical Trials in Guangzhou, Guangdong
7 recruitingGuangzhou, Guangdong, China
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Refractory CancerB-cell LymphomaB-cell Malignancy+1 more
BeOne Medicines80 enrolled50 locationsNCT06634589
Recruiting
Phase 2
A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL)
Guangzhou Lupeng Pharmaceutical Company LTD.150 enrolled41 locationsNCT07189065
Recruiting
Phase 2Phase 3
Xinlikang Capsule for Chemotherapy-induced Fatigue and Immune Disorders in Diffuse Large B Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL)
Sun Yat-sen University80 enrolled1 locationNCT07084662
Recruiting
Phase 1
A Study of LP-168 in Participants With Relapse or Refractory B-Cell Lymphoma
B-cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.200 enrolled3 locationsNCT04993690
Recruiting
Phase 2
Sintilimab Plus Rituximab Followed by R-CHOP Regimen in Untreated PMBL
Primary Mediastinal Diffuse Large B-cell Lymphoma
Sun Yat-sen University30 enrolled2 locationsNCT06742502
Recruiting
Phase 1
Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies
Multiple MyelomaB-cell LymphomaHematological Malignancy
The Third Affiliated Hospital of Southern Medical University60 enrolled1 locationNCT06758713
Recruiting
Phase 2
A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma
B-cell Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.80 enrolled30 locationsNCT06566586